82_FR_29210 82 FR 29088 - National Institute of Allergy and Infectious Disease; Notice of Closed Meetings

82 FR 29088 - National Institute of Allergy and Infectious Disease; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 122 (June 27, 2017)

Page Range29088-29089
FR Document2017-13361

Federal Register, Volume 82 Issue 122 (Tuesday, June 27, 2017)
[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)]
[Notices]
[Pages 29088-29089]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-13361]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Disease; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 29089]]

amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Systems Biology: The Next 
Generation for Infectious Diseases (U19).
    Date: July 19-20, 2017.
    Time: 8:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, Salon 
B, 5701 Marinelli Road, Bethesda, MD 20852.
    Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, Room 
3G62A, National Institutes of Health, NIAID, 5601 Fishers Lane, MSC 
9823, Bethesda, MD 2089-9823, (240) 669-5081, [email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Planning Grant 
(R34).
    Date: July 20, 2017.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 3F100 Resource Library, 
5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Robert C. Unfer, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3F40A, National Institutes of Health, NIAID, 5601 
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5035, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: June 21, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-13361 Filed 6-26-17; 8:45 am]
BILLING CODE 4140-01-P



                                                  29088                          Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices

                                                  Leroy A. Richardson,                                      The Director, Management Analysis                      Dated: June 21, 2017.
                                                  Chief, Information Collection Review Office,            and Services Office, has been delegated                Melanie J. Pantoja,
                                                  Office of Scientific Integrity, Office of the           the authority to sign Federal Register                 Program Analyst, Office of Federal Advisory
                                                  Associate Director for Science, Office of the           notices pertaining to announcements of                 Committee Policy.
                                                  Director, Centers for Disease Control and               meetings and other committee                           [FR Doc. 2017–13358 Filed 6–26–17; 8:45 am]
                                                  Prevention.
                                                                                                          management activities, for both the                    BILLING CODE 4140–01–P
                                                  [FR Doc. 2017–13414 Filed 6–26–17; 8:45 am]
                                                                                                          Centers for Disease Control and
                                                  BILLING CODE 4163–18–P                                  Prevention and the Agency for Toxic
                                                                                                          Substances and Disease Registry.                       DEPARTMENT OF HEALTH AND
                                                                                                                                                                 HUMAN SERVICES
                                                  DEPARTMENT OF HEALTH AND                                Elaine L. Baker,
                                                  HUMAN SERVICES                                          Director, Management Analysis and Services             National Institutes of Health
                                                                                                          Office, Centers for Disease Control and
                                                  Centers for Disease Control and                         Prevention.                                            National Institute on Aging; Notice of
                                                  Prevention                                              [FR Doc. 2017–13339 Filed 6–26–17; 8:45 am]            Closed Meeting
                                                                                                          BILLING CODE 4163–18–P
                                                  Advisory Committee to the Director                                                                               Pursuant to section 10(d) of the
                                                  (ACD), Centers for Disease Control and                                                                         Federal Advisory Committee Act, as
                                                  Prevention—State, Tribal, Local and                     DEPARTMENT OF HEALTH AND                               amended (5 U.S.C. App.), notice is
                                                  Territorial (STLT) Subcommittee                         HUMAN SERVICES                                         hereby given of the following meeting.
                                                                                                                                                                   The meeting will be closed to the
                                                    In accordance with section 10(a)(2) of                                                                       public in accordance with the
                                                  the Federal Advisory Committee Act                      National Institutes of Health
                                                                                                                                                                 provisions set forth in sections
                                                  (Pub. L. 92–463), the Centers for Disease                                                                      552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                          National Cancer Institute; Notice of
                                                  Control and Prevention (CDC)                                                                                   as amended. The grant applications and
                                                                                                          Closed Meeting
                                                  announces the following meeting of the                                                                         the discussions could disclose
                                                  aforementioned subcommittee:                              Pursuant to section 10(d) of the                     confidential trade secrets or commercial
                                                  TIME AND DATE: 8:30 a.m.–3:30 p.m.,                     Federal Advisory Committee Act, as                     property such as patentable material,
                                                  EDT, August 11, 2017.                                   amended (5 U.S.C. App.), notice is                     and personal information concerning
                                                  PLACE: CDC, Building 19, Rooms 245–                     hereby given of the following meeting.                 individuals associated with the grant
                                                  246, 1600 Clifton Road, NE., Atlanta,                                                                          applications, the disclosure of which
                                                                                                            The meeting will be closed to the
                                                  Georgia 30329. This meeting will also be                                                                       would constitute a clearly unwarranted
                                                                                                          public in accordance with the
                                                  held by teleconference.                                                                                        invasion of personal privacy.
                                                                                                          provisions set forth in sections
                                                  STATUS: Open to the public, limited
                                                                                                          552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,               Name of Committee: National Institute on
                                                  only by the space available. The meeting                as amended. The grant applications and                 Aging Special Emphasis Panel; ‘‘Relationship
                                                  room accommodates approximately 20                      the discussions could disclose                         between Delirium and Alzheimer’s disease’’.
                                                  people. The public is welcome to                        confidential trade secrets or commercial                 Date: July 21, 2017.
                                                  participate during the public comment,                  property such as patentable material,
                                                                                                                                                                   Time: 11:00 a.m. to 3:00 p.m.
                                                  which is tentatively scheduled from                                                                              Agenda: To review and evaluate grant
                                                                                                          and personal information concerning                    applications.
                                                  2:45 p.m. to 2:55 p.m., EDT. To                         individuals associated with the grant
                                                  participate on the teleconference, please                                                                        Place: National Institute on Aging,
                                                                                                          applications, the disclosure of which                  Gateway Building, 2C223, 7201 Wisconsin
                                                  dial 866–917–2712 and enter code                        would constitute a clearly unwarranted                 Ave., Bethesda, MD 20892 (Telephone
                                                  9418625.                                                invasion of personal privacy.                          Conference Call).
                                                  PURPOSE: The Subcommittee will                                                                                   Contact Person: Isis S. Mikhail, MD, MPH,
                                                  provide advice to the ACD on strategies,                  Name of Committee: National Cancer
                                                                                                                                                                 DRPH, National Institute on Aging, Gateway
                                                                                                          Institute Special Emphasis Panel; Cancer               Building, 7201 Wisconsin Avenue, Suite
                                                  future needs, and challenges faced by                   Biomarkers and Bio Specimens.
                                                  State, Tribal, Local and Territorial                                                                           2C212, Bethesda, MD 20892, 301–402–7704,
                                                                                                            Date: July 27, 2017.                                 Mikhaili@Mail.NIH.gov.
                                                  health agencies, and will provide                         Time: 10:00 a.m. to 6:00 p.m.
                                                  guidance on opportunities for CDC                         Agenda: To review and evaluate grant                 (Catalogue of Federal Domestic Assistance
                                                  through the ACD.                                        applications.                                          Program Nos. 93.866, Aging Research,
                                                                                                            Place: National Cancer Institute Shady               National Institutes of Health, HHS)
                                                  MATTERS FOR DISCUSSION: The STLT
                                                  Subcommittee members will discuss                       Grove, 9609 Medical Center Drive, Room                   Dated: June 21, 2017.
                                                  progress on implementation of ACD-                      7W264, Bethesda, MD 20892–9750                         Melanie J. Pantoja,
                                                                                                          (Telephone Conference Call).
                                                  adopted recommendations related to the                    Contact Person: Reed A. Graves, Ph.D.,
                                                                                                                                                                 Program Analyst, Office of Federal Advisory
                                                  health department of the future, other                                                                         Committee Policy.
                                                                                                          Scientific Review Officer, Research
                                                  emerging challenges and how CDC can                     Technology and Contract Review Branch,                 [FR Doc. 2017–13360 Filed 6–26–17; 8:45 am]
                                                  best support STLT health departments                    Division of Extramural Activities, National            BILLING CODE 4140–01–P
                                                  in the transforming health system.                      Cancer Institute, NIH, 9609 Medical Center
                                                    The agenda is subject to change as                    Drive, Room 7W264, Bethesda, MD 20892–
                                                  priorities dictate.                                     9750 240–276–6384, gravesr@mail.nih.gov.               DEPARTMENT OF HEALTH AND
                                                  CONTACT PERSON FOR MORE INFORMATION:                    (Catalogue of Federal Domestic Assistance              HUMAN SERVICES
                                                  José Montero, MD, Designated Federal                   Program Nos. 93.392, Cancer Construction;
mstockstill on DSK30JT082PROD with NOTICES




                                                  Officer, STLT Subcommittee, ACD,                        93.393, Cancer Cause and Prevention                    National Institutes of Health
                                                                                                          Research; 93.394, Cancer Detection and
                                                  CDC, 4770 Buford Highway, MS E70,
                                                                                                          Diagnosis Research; 93.395, Cancer                     National Institute of Allergy and
                                                  Atlanta, GA 30341, Telephone (404)                      Treatment Research; 93.396, Cancer Biology             Infectious Disease; Notice of Closed
                                                  498–0259, email: OSTLTSDirector@                        Research; 93.397, Cancer Centers Support;              Meetings
                                                  cdc.gov. Please submit comments to                      93.398, Cancer Research Manpower; 93.399,
                                                  OSTLTSDirector@cdc.gov no later than                    Cancer Control, National Institutes of Health,           Pursuant to section 10(d) of the
                                                  August 4, 2017.                                         HHS)                                                   Federal Advisory Committee Act, as


                                             VerDate Sep<11>2014   18:33 Jun 26, 2017   Jkt 241001   PO 00000   Frm 00067   Fmt 4703   Sfmt 4703   E:\FR\FM\27JNN1.SGM   27JNN1


                                                                                 Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices                                                  29089

                                                  amended (5 U.S.C. App.), notice is                      DEPARTMENT OF HEALTH AND                               DEPARTMENT OF HEALTH AND
                                                  hereby given of the following meetings.                 HUMAN SERVICES                                         HUMAN SERVICES
                                                    The meetings will be closed to the
                                                                                                          National Institutes of Health                          National Institutes of Health
                                                  public in accordance with the
                                                  provisions set forth in sections                                                                               National Cancer Institute Amended;
                                                                                                          National Institute of General Medical
                                                  552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,                                                                     Notice of Meeting
                                                                                                          Sciences; Notice of Closed Meeting
                                                  as amended. The grant applications and
                                                  the discussions could disclose                            Pursuant to section 10(d) of the                       Notice is hereby given of a change in
                                                  confidential trade secrets or commercial                Federal Advisory Committee Act, as                     the meeting of the National Cancer
                                                  property such as patentable material,                   amended (5 U.S.C. App.), notice is                     Institute Special Emphasis Panel, June
                                                  and personal information concerning                     hereby given of the following meeting.                 30, 2017, 8:00 a.m. to June 30, 2017,
                                                  individuals associated with the grant                                                                          6:00 p.m., Bethesda North Marriott
                                                                                                            The meeting will be closed to the                    Hotel & Conference Center, 5701
                                                  applications, the disclosure of which
                                                                                                          public in accordance with the                          Marinelli Road, Bethesda, MD, 20852
                                                  would constitute a clearly unwarranted
                                                                                                          provisions set forth in sections                       which was published in the Federal
                                                  invasion of personal privacy.
                                                                                                          552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,             Register on May 5, 2017, 82 FR 21256.
                                                    Name of Committee: National Institute of              as amended. The grant applications and
                                                  Allergy and Infectious Diseases Special                                                                          The meeting notice is amended to
                                                                                                          the discussions could disclose
                                                  Emphasis Panel; Systems Biology: The Next                                                                      change the meeting start time to 7:00
                                                                                                          confidential trade secrets or commercial               a.m. The meeting is closed to the public.
                                                  Generation for Infectious Diseases (U19).
                                                                                                          property such as patentable material,
                                                    Date: July 19–20, 2017.                                                                                        Dated: June 21, 2017.
                                                                                                          and personal information concerning
                                                    Time: 8:00 a.m. to 5:30 p.m.                                                                                 Melanie J. Pantoja,
                                                    Agenda: To review and evaluate grant
                                                                                                          individuals associated with the grant
                                                                                                          applications, the disclosure of which                  Program Analyst, Office of Federal Advisory
                                                  applications.                                                                                                  Committee Policy.
                                                    Place: Bethesda North Marriott Hotel &                would constitute a clearly unwarranted
                                                                                                          invasion of personal privacy.                          [FR Doc. 2017–13359 Filed 6–26–17; 8:45 am]
                                                  Conference Center, Salon B, 5701 Marinelli
                                                                                                                                                                 BILLING CODE 4140–01–P
                                                  Road, Bethesda, MD 20852.                                 Name of Committee: National Institute of
                                                    Contact Person: Eleazar Cohen, Ph.D.,                 General Medical Sciences Special Emphasis
                                                  Scientific Review Officer, Scientific Review            Panel; Review of PO1 Applications.                     DEPARTMENT OF HEALTH AND
                                                  Program, Division of Extramural Activities,               Date: June 26, 2017.                                 HUMAN SERVICES
                                                  Room 3G62A, National Institutes of Health,                Time: 12:00 p.m. to 3:00 p.m.
                                                  NIAID, 5601 Fishers Lane, MSC 9823,                       Agenda: To review and evaluate grant                 National Institutes of Health
                                                  Bethesda, MD 2089–9823, (240) 669–5081,                 applications.
                                                  ecohen@niaid.nih.gov.                                     Place: National Institutes of Health,                National Institute of Neurological
                                                    Name of Committee: National Institute of              Natcher Building, Room 3An.12N, 45 Center              Disorders and Stroke; Notice of Closed
                                                  Allergy and Infectious Diseases Special                 Drive, Bethesda, MD 20892 (Telephone                   Meetings
                                                  Emphasis Panel; NIAID Clinical Trial                    Conference Call).
                                                  Planning Grant (R34).                                     Contact Person: Lisa Dunbar, Ph.D.,                    Pursuant to section 10(d) of the
                                                    Date: July 20, 2017.                                  Scientific Review Officer, Office of Scientific        Federal Advisory Committee Act, as
                                                    Time: 1:00 p.m. to 3:00 p.m.                          Review, National Institute of General Medical          amended (5 U.S.C. App.), notice is
                                                    Agenda: To review and evaluate grant                  Sciences, National Institutes of Health, 45            hereby given of the following meetings.
                                                  applications.                                           Center Drive, Room 3AN12, Bethesda, MD
                                                                                                                                                                   The meetings will be closed to the
                                                    Place: National Institutes of Health, 3F100           20892, 301–594–2849, dunbarl@mail.nih.gov.
                                                                                                                                                                 public in accordance with the
                                                  Resource Library, 5601 Fishers Lane,                      This notice is being published less than 15          provisions set forth in sections
                                                  Rockville, MD 20892 (Telephone Conference               days prior to the meeting due to the timing            552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                  Call).                                                  limitations imposed by the review and                  as amended. The grant applications and
                                                    Contact Person: Robert C. Unfer, Ph.D.,               funding cycle.                                         the discussions could disclose
                                                  Scientific Review Officer, Scientific Review            (Catalogue of Federal Domestic Assistance              confidential trade secrets or commercial
                                                  Program, Division of Extramural Activities,             Program Nos. 93.375, Minority Biomedical               property such as patentable material,
                                                  Room 3F40A, National Institutes of Health,              Research Support; 93.821, Cell Biology and
                                                  NIAID, 5601 Fishers Lane, MSC 9823,
                                                                                                                                                                 and personal information concerning
                                                                                                          Biophysics Research; 93.859, Pharmacology,             individuals associated with the grant
                                                  Bethesda, MD 20892–9823, (240) 669–5035,                Physiology, and Biological Chemistry
                                                  robert.unfer@nih.gov.
                                                                                                                                                                 applications, the disclosure of which
                                                                                                          Research; 93.862, Genetics and                         would constitute a clearly unwarranted
                                                  (Catalogue of Federal Domestic Assistance               Developmental Biology Research; 93.88,                 invasion of personal privacy.
                                                  Program Nos. 93.855, Allergy, Immunology,               Minority Access to Research Careers; 93.96,
                                                  and Transplantation Research; 93.856,                   Special Minority Initiatives; 93.859,                    Name of Committee: National Institute of
                                                  Microbiology and Infectious Diseases                                                                           Neurological Disorders and Stroke Special
                                                                                                          Biomedical Research and Research Training,
                                                                                                                                                                 Emphasis Panel; CREATE Device Review.
                                                  Research, National Institutes of Health, HHS)           National Institutes of Health, HHS)                      Date: July 13, 2017.
                                                    Dated: June 21, 2017.                                   Dated: June 21, 2017.                                  Time: 8:00 a.m. to 6:00 p.m.
                                                  Natasha M. Copeland,                                                                                             Agenda: To review and evaluate grant
                                                                                                          Melanie J. Pantoja,
                                                                                                                                                                 applications.
mstockstill on DSK30JT082PROD with NOTICES




                                                  Program Analyst, Office of Federal Advisory             Program Analyst, Office of Federal Advisory              Place: Hilton Alexandria Mark Center,
                                                  Committee Policy.                                       Committee Policy.                                      5000 Seminary Road, Alexandria, VA 22311.
                                                  [FR Doc. 2017–13361 Filed 6–26–17; 8:45 am]             [FR Doc. 2017–13362 Filed 6–26–17; 8:45 am]              Contact Person: Joel Saydoff, Ph.D.,
                                                  BILLING CODE 4140–01–P                                  BILLING CODE 4140–01–P                                 Scientific Review Officer, Scientific Review
                                                                                                                                                                 Branch, NINDS/NIH/DHHS, Neuroscience
                                                                                                                                                                 Center, 6001 Executive Blvd., Suite 3204,
                                                                                                                                                                 MSC 9529, Bethesda, MD 20892–9529, (301)
                                                                                                                                                                 496–9223, joel.saydoff@nih.gov.



                                             VerDate Sep<11>2014   18:33 Jun 26, 2017   Jkt 241001   PO 00000   Frm 00068   Fmt 4703   Sfmt 4703   E:\FR\FM\27JNN1.SGM   27JNN1



Document Created: 2018-11-14 10:15:26
Document Modified: 2018-11-14 10:15:26
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 19-20, 2017.
FR Citation82 FR 29088 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR